The essential role of pharmacists facilitating vaccination in older adults: the case of Herpes Zoster

Public hesitancy to COVID‐19 vaccine and the role of pharmacists in addressing the problem and improving uptake

“…26 Similarly, community pharmacists have been contributing to vaccination‐related services in countries such as the US and Canada even before COVID‐19. 27 , 28 In Australia, although community pharmacists have had limited opportunity to contribute to vaccination services, there have been encouraging trends in recent years and particularly in the fight against COVID‐19. 29 In July 2021, the Australian government invited appropriately trained pharmacists to join the COVID‐19 national vaccine rollout and these have since become a major point of access for COVID‐19 vaccines across the country including in regional and remote areas.…”

Public Health Interest of Vaccination Through Community Pharmacies: A Literature Review

“…the pharmacy; (3) articles on the interest of vaccination in the pharmacy for patients with comorbidities. These articles were excluded to retain a general focus on the whole population; (4) articles on the legislative changes necessary for the implementation of vaccination in pharmacies; (5) A broader search on economic aspects was also conducted in a second step. This latter review was not intended to synthesize all the available literature but rather to delve into the economic constraints and benefits of vaccination by pharmacists and to assess its economic interest.…”

“…Vaccination is the most cost-effective, and lowrisk preventive measure [4][5][6][7] . It significantly reduces infectious disease rates, hospitalizations, and health care costs 2,8 .…”

“…For instance, in Poland, the influenza vaccination rate among people over 65 is below 10% 19 . In the United States, influenza vaccination goals among healthy people were not met in 2020 20 : the vaccination coverage goal was 70% for adults over 18 years of age, but the actual coverage was only 45.4% in 2017 5 .…”

“…As a result, many vaccine-preventable diseases still cause significant death, contamination, as well as public finance and health care costs. For example, in the United States, 40,000 to 50,000 people die each year from vaccine-preventable infectious diseases 21 , which represents an annual economic burden of 9 billion USD (76% of this burden being due to people over 50 years old) 5 . This burden could increase further over the next 30 years, especially for influenza, pertussis, shingles and pneumococcus.…”